|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 45/06 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61K 31/575 | (2006.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61K 31/4178 | (2006.01) | ||
| A61K 31/41 | (2013.01) | ||
| A61K 31/41 | (2006.01) | ||
| A61K 31/4178 | (2013.01) | ||
| A61K 31/4184 | (2006.01) | ||
| A61K 31/4184 | (2013.01) | ||
| A61K 31/42 | (2006.01) | ||
| A61K 31/42 | (2013.01) | ||
| A61K 31/4245 | (2006.01) | ||
| A61K 31/4245 | (2013.01) | ||
| A61K 31/454 | (2006.01) | ||
| A61K 31/454 | (2013.01) | ||
| A61K 31/46 | (2006.01) | ||
| A61K 31/46 | (2013.01) | ||
| A61P 1/16 | (2006.01) | ||
| A61K 31/575 | (2013.01) |
| (11) | Patento numeris | 3437659 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17774971.0 |
| Europos patento paraiškos padavimo data | 2017-03-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-02-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-03-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2017/012448 |
| Data | 2017-03-27 |
| (87) | Numeris | WO 2017/170434 |
| Data | 2017-10-05 |
| (30) | Numeris | Data | Šalis |
| 2016064475 | 2016-03-28 | JP |
| (72) |
NAMISAKI, Tadashi , JP
YOSHIJI, Hitoshi , JP
|
| (73) |
Intercept Pharmaceuticals, Inc. ,
305 Madison Avenue, Morristown NJ 07960,
US
|
| (54) | COMBINATION OF A FXR AGONIST AND AN ANGIOTENSIN II RECEPTOR BLOCKER |
| COMBINATION OF A FXR AGONIST AND AN ANGIOTENSIN II RECEPTOR BLOCKER |